Intellectual Property Strategy for Nanoparticle Drug Delivery Platforms
Platform patents multiply value by stacking composition, method, and application claims together.
Platform patents multiply value by stacking composition, method, and application claims together.
The drug works through appetite suppression and also activates brown fat to burn energy.
These drugs work far beyond blood sugar control across multiple organs.
High-dose GLP-1 drugs may spare muscle more than previously thought.
Multiple studies suggest GLP-1 drugs may prevent dementia, not reverse it.
Stronger binding and enzyme resistance give semaglutide a dosing edge over liraglutide.
Enzymatic barriers and tight junctions make nasal delivery far harder than injection for peptides.
Scientists engineer peptides to survive the body's defenses without injections.
Nasal delivery could ease GLP-1 side effects while boosting brain concentrations.
Nanoparticles engineered to protect peptides through nasal passages and into the brain.
Approved nanoparticles solve specific delivery failures free drugs cannot overcome.
Researchers race to unlock delivery methods as barrier blocks ninety-eight percent of brain drugs.